BioMaxima S.A. (WSE:BMX)
Poland flag Poland · Delayed Price · Currency is PLN
9.58
-0.10 (-1.03%)
Jun 16, 2026, 3:44 PM CET

BioMaxima Revenue

In the year 2025, BioMaxima had annual revenue of 60.90M PLN with 15.24% growth. BioMaxima had revenue of 17.68M in the quarter ending December 31, 2025, with 11.28% growth.

Revenue
60.90M
Revenue Growth
+15.24%
P/S Ratio
0.67
Revenue / Employee
451.14K
Employees
135
Market Cap
40.59M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202560.90M8.05M15.24%
Dec 31, 202452.85M6.07M12.96%
Dec 31, 202346.79M-97.08M-67.48%
Dec 31, 2022143.87M64.78M81.91%
Dec 31, 202179.09M17.81M29.06%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
NEUCA13.83B
Diagnostyka2.51B
Synektik Spólka Akcyjna794.94M
Voxel583.14M
Read-Gene16.54M
Sygnis13.02M
Pharmena1.61M
Nestmedic1.02M
Revenue Rankings